EP1144632A3 - Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation - Google Patents

Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation

Info

Publication number
EP1144632A3
EP1144632A3 EP99967625A EP99967625A EP1144632A3 EP 1144632 A3 EP1144632 A3 EP 1144632A3 EP 99967625 A EP99967625 A EP 99967625A EP 99967625 A EP99967625 A EP 99967625A EP 1144632 A3 EP1144632 A3 EP 1144632A3
Authority
EP
European Patent Office
Prior art keywords
immunotherapy
diagnosis
compounds
methods
colon cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99967625A
Other languages
German (de)
English (en)
Other versions
EP1144632A2 (fr
Inventor
Jiangchun Xu
Michael J. Lodes
Heather Secrist
Darin R. Benson
Madeleine Joy Meagher
John Stolk
Tongtong Wang
Yuqiu Jiang Kent Wa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/221,298 external-priority patent/US6284241B1/en
Priority claimed from US09/401,064 external-priority patent/US6623923B1/en
Priority claimed from US09/444,242 external-priority patent/US6697837B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Priority to EP06002432A priority Critical patent/EP1715043A3/fr
Priority to EP06025304A priority patent/EP1767636A3/fr
Publication of EP1144632A2 publication Critical patent/EP1144632A2/fr
Publication of EP1144632A3 publication Critical patent/EP1144632A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99967625A 1998-12-23 1999-12-23 Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation Withdrawn EP1144632A3 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06002432A EP1715043A3 (fr) 1998-12-23 1999-12-23 Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
EP06025304A EP1767636A3 (fr) 1998-12-23 1999-12-23 Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US221298 1980-12-30
US09/221,298 US6284241B1 (en) 1998-12-23 1998-12-23 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US34749699A 1999-07-02 1999-07-02
US347496 1999-07-02
US09/401,064 US6623923B1 (en) 1998-12-23 1999-09-22 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US401064 1999-09-22
US09/444,242 US6697837B1 (en) 1999-11-19 1999-11-19 End user profiling method
US444242 1999-11-19
US45415099A 1999-12-02 1999-12-02
US454150 1999-12-02
PCT/US1999/030909 WO2000037643A2 (fr) 1998-12-23 1999-12-23 Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP06002432A Division EP1715043A3 (fr) 1998-12-23 1999-12-23 Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
EP06025304A Division EP1767636A3 (fr) 1998-12-23 1999-12-23 Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation

Publications (2)

Publication Number Publication Date
EP1144632A2 EP1144632A2 (fr) 2001-10-17
EP1144632A3 true EP1144632A3 (fr) 2001-11-07

Family

ID=27539822

Family Applications (3)

Application Number Title Priority Date Filing Date
EP06002432A Withdrawn EP1715043A3 (fr) 1998-12-23 1999-12-23 Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
EP06025304A Withdrawn EP1767636A3 (fr) 1998-12-23 1999-12-23 Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation
EP99967625A Withdrawn EP1144632A3 (fr) 1998-12-23 1999-12-23 Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EP06002432A Withdrawn EP1715043A3 (fr) 1998-12-23 1999-12-23 Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
EP06025304A Withdrawn EP1767636A3 (fr) 1998-12-23 1999-12-23 Composés destinés à l'immunothérapie et au diagnostic du cancer du colon et méthodes d'utilisation

Country Status (6)

Country Link
EP (3) EP1715043A3 (fr)
JP (1) JP2002533082A (fr)
AU (1) AU2387900A (fr)
CA (1) CA2356987A1 (fr)
HK (1) HK1041025A1 (fr)
WO (1) WO2000037643A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358508B1 (en) 1997-06-11 2002-03-19 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor TR9
US6949339B1 (en) 1998-05-21 2005-09-27 Diadexus, Inc. Method of diagnosing, monitoring, and staging colon cancer
US6623923B1 (en) 1998-12-23 2003-09-23 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US6962779B1 (en) 1998-10-02 2005-11-08 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
CA2350776C (fr) 1998-11-10 2011-05-03 Emory University Nouveaux regulateurs mitogeniques
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
JP2003529325A (ja) * 1999-06-17 2003-10-07 インサイト・ゲノミックス・インコーポレイテッド ヒト輸送タンパク質
AU1807401A (en) 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1242598A2 (fr) * 1999-12-30 2002-09-25 Corixa Corporation Composes pour l'immunotherapie et le diagnostic du cancer du colon et procedes d'utilisation
WO2001077168A2 (fr) * 2000-04-11 2001-10-18 Corixa Corporation Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon
EP1661995A1 (fr) * 2000-05-26 2006-05-31 Diadexus, Inc. Procédé permettant de diagnostiquer, de surveiller, de stadifier, de visualiser et de traiter le cancer du colon
US6635750B1 (en) * 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
WO2002012280A2 (fr) * 2000-08-03 2002-02-14 Corixa Corporation Compositions et procedes pour le diagnostic et le traitement du cancer du colon
CA2417866A1 (fr) * 2000-08-03 2002-02-14 Corixa Corporation Compositions et methodes utilisees dans la therapie et le diagnostic du cancer du colon
AU2001294999A1 (en) * 2000-08-07 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20040110668A1 (en) * 2000-10-02 2004-06-10 Burgess Christopher C. Nucleic acid sequences differentially expressed in cancer tissue
AU2002257266A1 (en) * 2001-05-17 2002-11-25 Pe Corporation (Ny) Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20030129207A1 (en) * 2001-08-21 2003-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
WO2003025214A1 (fr) * 2001-09-14 2003-03-27 Medimolecular Pty. Ltd. Nouveaux marqueurs et utilisation de ceux-ci
WO2003097872A2 (fr) * 2002-05-21 2003-11-27 Mtm Laboratories Ag Procede in-vitro permettant de detecter des lesions colorectales
EP1365242A1 (fr) * 2002-05-21 2003-11-26 MTM Laboratories AG Composés pour le diagnostique et le traitement de lésions colorectales
KR100568755B1 (ko) * 2003-04-03 2006-04-07 주식회사 리젠 바이오텍 Ｙｈ 모티프를 포함하는 펩타이드를 유효성분으로함유하는 혈관신생 억제제
EP2311468B1 (fr) 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gène surexprimé dans le cancer
DE10341812A1 (de) * 2003-09-10 2005-04-07 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP2123758A1 (fr) * 2008-05-20 2009-11-25 Wageningen Universiteit Séquence de tête coiffée ("CAP leader sequence") du virus de la grippe

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001020A2 (fr) * 1997-07-01 1999-01-14 Human Genome Sciences, Inc. 19 proteines secretees humaines
WO1998039448A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 nouvelles proteines secretees
AU7499198A (en) * 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells
CA2291260A1 (fr) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 proteines secretees par l'etre humain
DE19817557A1 (de) * 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor
EP1080227B1 (fr) * 1998-05-21 2006-02-08 Diadexus, Inc. Procédé de diagnostic, de surveillance et de détermination du stade du cancer du colon
CA2328895A1 (fr) * 1998-06-02 1999-12-09 Genentech, Inc. Proteines membranaires et acides nucleiques codant ces proteines
CA2373915A1 (fr) * 1999-06-02 2000-12-07 Genentech, Inc. Procedes et compositions visant a inhiber la proliferation des cellules cancereuses
ATE478145T1 (de) * 1999-06-02 2010-09-15 Genentech Inc Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren
AU2575601A (en) * 1999-12-10 2001-06-18 Incyte Genomics, Inc. Extracellular matrix and cell adhesion molecules

Also Published As

Publication number Publication date
EP1144632A2 (fr) 2001-10-17
AU2387900A (en) 2000-07-12
EP1715043A2 (fr) 2006-10-25
JP2002533082A (ja) 2002-10-08
WO2000037643A3 (fr) 2001-08-09
WO2000037643A2 (fr) 2000-06-29
EP1767636A2 (fr) 2007-03-28
EP1767636A3 (fr) 2007-06-13
CA2356987A1 (fr) 2000-06-29
EP1715043A3 (fr) 2007-01-10
HK1041025A1 (zh) 2002-06-28

Similar Documents

Publication Publication Date Title
EP1144632A3 (fr) Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
IL131560A0 (en) Compounds for immunotherapy of prostate cancer and methods for their use
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2766399A (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
AU4473596A (en) Methods of human prostate cancer diagnosis
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2608201A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU7484800A (en) Imaging of scattering media using relative detector values
AU3105700A (en) Methods for detection of antiestrogen-resistant breast cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
HUP0200991A2 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU4150999A (en) Method and kit for early diagnosis of cancer
AU2003218208A1 (en) Methods for diagnosis and prognosis of cancer
AU9689398A (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20010713

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: WA, YUQIU, JIANG ,KENT

Inventor name: WANG, TONGTONG

Inventor name: STOLK, JOHN

Inventor name: MEAGHER, MADELEINE, JOY

Inventor name: BENSON, DARIN, R.

Inventor name: SECRIST, HEATHER

Inventor name: LODES, MICHAEL, J.

Inventor name: XU, JIANGCHUN

17Q First examination report despatched

Effective date: 20050530

17Q First examination report despatched

Effective date: 20050530

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1041025

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090701